The economic evaluation was based on a decision-analytic Markov model, which evaluated the cost-effectiveness of various vaccinations for HPV from a health care provider perspective.

We developed a Markov model of osteoporosis that is capable of estimating the long-term costs and health benefits of tibolone therapy based on two key relationships.